February 6, 2025 India's Aurobindo Pharma posts third-quarter profit drop on higher expenses Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in ...

Mironov, council members, along with Mercer County Executive Dan Benson, joined Aurobindo Chief Executive Officer Swami Iyer ...

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

Anil Singhvi gave buy advice on Aurobindo Pharma Fut, Dr Reddy's Fut & Lupin Fut. The stock target for Aurobindo Pharma is ₹1220, ₹1250 and ₹1275 and a stoploss is kept at ₹1150, whereas for Dr ...

Aurobindo Pharma Ltd, Gland Pharma Ltd, Lupin Ltd and Dr Reddy's Labs Ltd led pharma sector gainers on Thursday, as despite levying a 26 per cent tariff on India overnight, the Trump ...

Ltd. in an interview with CNBC-TV18 ... On Thursday's session Nifty Pharma surged nearly 4% with Gland Pharma, Lupin, Aurobindo Pharma, Natco Pharma, Sun Pharmaceutical Industries leading the ...

Aurobindo Pharma gets USFDA nod for acid reflux treatment drug Aurobindo Pharma Ltd today said it has received final approval from the US health regulator to manufacture and market Famotidine ...

Aurobindo’s Unit XI was inspected by US FDA between July 25-Aug 2, 2022 and issued three observations. In a regulatory filing on Friday, Aurobindo Pharma said, 'The board of directors in its ...